Catherine P. Leith

Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

Catherine P. Leith, Kenneth J. Kopecky, John E. Godwin et al. · Blood · 1997 · 868 citations

Medicine, Geriatric Medicine, Oncology +8

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

Catherine P. Leith, Kenneth J. Kopecky, I‐Ming Chen et al. · PubMed · 1999 · 579 citations · Full text

Medicine, Oncology, Pharmacology +13

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

William T. Beck, Thomas M. Grogan, Cheryl L. Willman et al. · PubMed · 1996 · 387 citations

Medicine, Oncology, Pharmacology +17

A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

John E. Godwin, Kenneth J. Kopecky, David R. Head et al. · Blood · 1998 · 310 citations · Full text

Medicine, Hematology, Oncology +10

Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells

Stephanie Markovina, Natalie S. Callander, Shelby L. O’Connor et al. · Molecular Cancer Research · 2008 · 146 citations · Full text

Medicine, Oncology, Pharmacology +13